SCHEMBL25469598

SCHEMBL25469598

CNCNC(=O)c1cccc(OCC(N=[N+]=[N-])OCC(=O)NCC#Cc2cn(C3CC(OCN=[N+]=[N-])C(COC)O3)c(=O)[nH]c2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TK1 P04183 1/20 0.34
▸ POLB P06746 2/20 0.32
▸ POLA1 P09884 1/20 0.32
▸ POLD1 P28340 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25469574 0.96 TK1 (0.33) TK1POLBPOLA1POLD1
SCHEMBL25469603 0.89 — —
SCHEMBL25469592 0.87 CA2 (0.36) —
SCHEMBL25469559 0.86 TK1 (0.40) TK1
SCHEMBL25469575 0.85 — —
SCHEMBL17227503 0.85 POLB (0.35) TK1POLBPOLA1POLD1
SCHEMBL13891877 0.85 POLB (0.35) TK1POLBPOLA1POLD1
SCHEMBL18269460 0.84 TK1 (0.33) TK1POLBPOLA1POLD1
SCHEMBL16805874 0.84 POLB (0.36) TK1POLBPOLA1POLD1
SCHEMBL15799880 0.84 POLB (0.38) TK1POLBPOLA1POLD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348968-A1 SHORT PENDANT ARM LINKERS FOR NUCLEOTIDES IN SEQUENCING APPLICATIONS ILLUMINA CAMBRIDGE LIMITED (GB) 2023-11-02 — — US disclosed
US-11655502-B2 Short pendant arm linkers for nucleotides in sequencing applications ILLUMINA CAMBRIDGE LIMITED (GB) 2023-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348968-A1 SHORT PENDANT ARM LINKERS FOR NUCLEOTIDES IN SEQUENCING APPLICATIONS POLRMT, POLM, POLN TK1 257/4885POLB 8/4885POLA1 93/4885
US-11655502-B2 Short pendant arm linkers for nucleotides in sequencing applications POLRMT, POLM, POLN TK1 257/4885POLB 8/4885POLA1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback